GLENDALE, Calif., Dec. 16, 2013 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-QB: AMEH), an integrated physician-driven, patient centric healthcare delivery company, today announced that Maverick Medical Group will be led by industry veteran Edward Rotan, who has been named Senior Vice President.
Maverick Medical Group is an Independent Physician Association (IPA) formed by ApolloMed to serve Medicare, Dual Eligible, Commercial and Medi-Cal patients residing in the Greater Los Angeles area.
For the past four decades, Mr. Rotan has earned industry distinction as a highly accomplished executive and operator of risk-bearing IPAs and management services organizations (MSOs) in California, Texas, Hawaii and Pennsylvania. He has been responsible for leading and growing several profitable IPAs and MSOs from relative start-ups to major industry players.
From 1992 to 2002, while serving as President of Medical Pathways, which included 16 IPAs, Mr. Rotan grew managed care lives from 2000 to more than 280,000. Prior to this, from 1982 until its sale to Aetna in 1992, he was President of Gateway Medical Group, where he was responsible for growing that company from two practices to 40 and increasing managed care lives to 180,000. Early in his career, he served as Chief Financial Officer of Redlands Community Hospital in Redlands, California, where he was credited with implementing efficiency programs that resulted in $20 million in cost savings to the hospital over an eight year period.
Additionally, in 2008, Mr. Rotan founded U.S. Dermatology Medical Management, an MSO that acquires, builds and manages dermatology practices. Under Rotan's leadership as President and CEO, U.S. Dermatology acquired multiple practices operating in California, Hawaii and Texas, before being sold to a private equity firm in 2011. Prior to this, as CEO of West Dermatology Medical Group, he grew the specialty IPA from five practices to 45, increasing annual revenues from $6 million to $70 million prior to its sale in 2008.
"Maverick IPA maintains a relentless focus on providing value to all of our end users – our physician partners, our contracted payors and all of our patients," noted Ed Rotan, Senior Vice President of Maverick IPA. "By providing our physicians with the highest possible levels of collaboration and efficiency, as well as an operational support infrastructure that utilizes the most advanced clinical and technology applications available, we believe we can ensure that our members receive best-in-class, cost effective medical attention across the full care continuum."
About Apollo Medical Holdings, Inc. (ApolloMed)
Headquartered in Glendale, California, ApolloMed is a leading provider of physician-driven integrated healthcare management services, fueled by its commitment to provide exceptional multi-disciplinary care in the communities it serves in Southern and Central California. ApolloMed is addressing the healthcare needs of the nation's largest population center by leveraging its integrated healthcare delivery platform comprised of three affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization) and Maverick Medical Group (Independent Physician Association). This platform combines hospitalist medicine, critical care medicine, case management and transition management that enable healthcare organizations to engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements. ApolloMed strives to improve medical outcomes with high quality, cost efficient care. For more information, please visit www.apollomed.net.
Forward Looking Statements
This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. ("the Company"). In particular, when used in the preceding discussion, the words "predicts," "believes," "expects," "intends," "seeks," "estimates," "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as "will," "may," "might," "should," "would" and "could" are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company's management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company's future results. The forward-looking statements included herein are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended January 31, 2013 and in any of the Company's other subsequent Securities and Exchange Commission filings.
FOR ADDITIONAL INFORMATION
407-585-1080 or via email at AMEH@hanoverelite.com
SOURCE Apollo Medical Holdings, Inc.